NAD+ Patches

Kind Patches NAD+ Patches are 30-count, single-use wellness patches built around nicotinamide mononucleotide (NMN), resveratrol, N-acetylcysteine (NAC), lion’s mane mushroom extract, and cordyceps extract. Despite the product name, the current ingredient declaration does not list NAD+ itself. Instead, it contains NMN, a precursor the body can use within NAD+ metabolism. Kind Patches markets the product around energy, vitality, cellular wellness, and youthful-looking skin, while Ulta places it within its beauty-supplement category.

The distinction between the ingredient research and the finished patch is especially important here. Human studies have investigated oral NMN, and a recent systematic review found that oral NMN supplementation can raise blood NAD concentrations. However, most clinically relevant metabolic outcomes included in that review were not significantly different from control, and the authors warned that benefits may sometimes be exaggerated. Those oral studies also do not establish how much NMN, resveratrol, NAC, lion’s mane, or cordyceps enters the bloodstream from this particular skin patch.

About NAD+ Patches

NAD+, or nicotinamide adenine dinucleotide, is a molecule naturally involved in cellular energy metabolism and many biochemical reactions throughout the body.

That scientific importance has led to considerable interest in compounds that influence NAD+ metabolism, especially NMN and nicotinamide riboside.

Kind Patches takes that concept and puts NMN into an adhesive patch rather than a conventional capsule or powder. The current formula contains 6 mg of NMN per patch along with four additional ingredients.

It is therefore useful to separate three ideas that are often blended together in NAD+ marketing:

NAD+ is an important molecule in human biology.

NMN has been studied as an NAD+ precursor.

A finished consumer patch containing NMN needs its own evidence to establish how much of that ingredient crosses intact human skin and what measurable effects the patch produces.

Evidence for the first two points does not automatically prove the third.

NAD+ Patches Features

The current Kind Patches formula contains five highlighted ingredients in measured amounts. NMN, resveratrol, and NAC are each listed at 6 mg, lion’s mane extract at 4 mg, and cordyceps extract at 3 mg. The pack contains 30 individual patches.

Kind Patches currently associates the formula with feelings of energy and resilience, youthful-looking skin, mental clarity, and general wellness. Ulta similarly presents claims around cellular energy, skin radiance, aging, and cellular repair. These should be understood as brand or retailer claims, not as independently demonstrated outcomes from a published clinical trial of the exact finished patch.

The product is also cruelty-free according to the manufacturer.

The Patch Contains NMN Rather Than NAD+

The product title is NAD+ Patches, but its ingredient panel does not list nicotinamide adenine dinucleotide.

It lists nicotinamide mononucleotide at 6 mg per patch.

NMN is involved in pathways that can contribute to NAD+ production, which explains the product name and marketing concept.

This distinction matters for technically accurate ecommerce content. Saying that each patch “contains NAD+” would be incorrect based on the current ingredient declaration.

The more accurate wording is:

NAD+ Patches contain NMN, an NAD+ precursor, as part of a five-ingredient wellness blend.

What Human NMN Research Actually Shows

NMN research has expanded considerably, but most human supplementation studies have evaluated oral administration, not consumer adhesive patches.

A 2023 randomized trial reported increased blood NAD concentrations after oral NMN supplementation and found oral doses up to 900 mg per day to be generally well tolerated during the study period.

Another controlled human study also reported increased blood NAD after oral NMN intake.

More importantly, a systematic review and meta-analysis published after reviewing 12 studies and 513 participants found that oral NMN produced a significant overall increase in blood NAD levels. However, most of the clinically important metabolic outcomes evaluated were not significantly different from control, and the researchers concluded that benefits of NMN supplementation may sometimes be overstated.

This provides useful scientific context without proving Kind Patches’ marketing claims.

Why Oral NMN Studies Cannot Be Applied Directly To A Patch

Route of administration matters.

Kind Patches contains 6 mg NMN per patch, while many oral human studies have investigated much larger oral quantities. That does not automatically mean the patch provides “too little” NMN because oral and transdermal delivery cannot be compared simply by reading the milligram numbers.

The problem is that the amount loaded into a patch is not necessarily the amount delivered through the skin.

The FDA describes transdermal delivery systems as technically complex products in which performance can depend on formulation, skin contact, adhesion, drug characteristics, delivery rate, and other design factors. For regulated transdermal medicines, delivery performance is specifically evaluated rather than assumed from the ingredient amount printed on the product.

Skin is designed to function as a barrier, so successful systemic delivery of an ingredient through intact skin is not automatic.

Transdermal Absorption Needs Product-Specific Evidence

A patch may look simple, but moving an ingredient from an adhesive layer, across the outer skin barrier, and into systemic circulation is a significant formulation challenge.

Reviews of transdermal delivery science describe the stratum corneum, the skin’s outer layer, as the major barrier restricting drug penetration. Molecular size, water and lipid solubility, concentration, formulation, penetration enhancers, contact area, and delivery technology can all influence what reaches deeper tissue.

This is why the statement that patches “bypass digestion” is incomplete by itself.

A substance cannot benefit from bypassing digestion unless an adequate amount first crosses the skin.

Kind Patches currently states that its patches provide direct absorption through the skin and can offer increased bioavailability. However, the manufacturer’s current NAD+ product information does not present a product-specific human pharmacokinetic trial quantifying how much of each of its five ingredients enters systemic circulation from this exact patch.

Erothots therefore would not describe increased bioavailability as an independently proven advantage of this specific product.

NMN At 6 mg Per Patch

Each patch contains 6 mg of Nicotinamide Mononucleotide.

NMN is the ingredient most directly connected with the NAD+ name.

Published human research gives NMN genuine scientific interest, but the strongest available evidence relates mainly to oral supplementation.

A useful product description should therefore avoid jumping from “NMN participates in NAD+ metabolism” to claims such as:

“reverses aging,”

“repairs DNA damage,”

“restores youthful NAD+ levels,”

or

“clinically proven to make users younger.”

Those statements are much stronger than the evidence available for this particular finished product.

The manufacturer itself states that its product claims have not been evaluated by the FDA and that the patches are not intended to diagnose, treat, cure, or prevent disease.

Resveratrol At 6 mg Per Patch

The second major ingredient is Resveratrol at 6 mg.

Resveratrol is a polyphenolic compound that has received considerable research attention in areas including oxidative stress, metabolism, and aging biology.

Kind Patches connects resveratrol with maintaining a radiant and youthful appearance, while Ulta uses stronger wording around antioxidant activity and visible aging.

Research on resveratrol as a compound does not establish the clinical performance of a 6 mg transdermal dose in this particular product.

The amount that reaches the skin or circulation from this patch is not reported in the product-specific human pharmacokinetic data currently presented by the manufacturer.

For that reason, resveratrol is best described as part of the product’s antioxidant-focused ingredient blend rather than as proof that the patch clinically stimulates collagen or reverses aging.

N-Acetylcysteine At 6 mg Per Patch

Each patch also contains 6 mg N-Acetylcysteine, commonly abbreviated NAC.

NAC has established biochemical relevance because it participates in pathways related to glutathione, an important endogenous antioxidant.

That does not mean every consumer format containing NAC has established systemic efficacy.

Ulta currently describes the ingredient as providing antioxidant protection, while Kind Patches uses more restrained language around general internal and external wellness and a youthful-looking complexion.

Again, the important missing link is product-specific transdermal delivery evidence.

The presence of NAC in the ingredient panel confirms what is loaded into the patch. It does not independently tell us what blood concentration results after wearing it.

Lion’s Mane Mushroom Extract

The patch contains 4 mg Lion’s Mane Mushroom Extract. Kind Patches connects this ingredient with mental clarity, focus, and emotional well-being.

Lion’s mane has attracted scientific research because it contains bioactive compounds such as hericenones and erinacines.

However, research on mushroom extracts taken orally or studied experimentally cannot simply be transferred to a 4 mg topical-patch format.

The exact extract specification is also important. The current ingredient declaration gives the ingredient name and amount but does not publish a detailed standardization level for specific lion’s-mane compounds.

Erothots therefore would not describe the patch as clinically proven to improve memory, cognition, or neurological function.

Cordyceps Extract

The final listed active is Cordyceps Extract at 3 mg.

Kind Patches associates it with energy, endurance, strength, and resilience.

As with lion’s mane, those claims need route-specific context.

Research on orally consumed mushroom extracts does not establish how effectively 3 mg of cordyceps extract is released from this adhesive patch or absorbed through intact human skin.

The manufacturer also does not provide a detailed standardization specification for the cordyceps extract on the current product page.

It is therefore most accurate to describe cordyceps as a supporting botanical in the wellness blend rather than as a clinically demonstrated performance enhancer in this format.

Cellular Energy Claims Need Careful Wording

NAD+ unquestionably participates in normal energy metabolism.

That biochemical fact is different from proving that a particular consumer patch creates a noticeable increase in human energy.

Ulta currently says the patches promote cellular energy, while Kind Patches describes improved feelings of vitality and youthful energy.

For an accurate Erothots page, the distinction should remain visible:

NAD+ biology: well established.

Oral NMN raising blood NAD in some human trials: supported by published research.

This exact patch reliably increasing circulating NAD+ or producing clinically significant energy improvements: not established by product-specific clinical data presented on the current manufacturer page.

This avoids turning legitimate NAD+ science into evidence for a delivery format that has not been studied to the same extent.

Anti-Aging Claims And Realistic Expectations

“Anti-aging” is one of the strongest themes surrounding NAD+ products.

The term can mean several completely different things, including improving how skin looks, influencing laboratory biomarkers, changing metabolic function, or extending lifespan.

Those outcomes should never be treated as interchangeable.

Kind Patches describes youthful appearance and energy, while Ulta refers to combating the effects of aging.

Current human NMN research does not establish that this Kind Patches product reverses biological aging in people.

Even the broader oral-NMN evidence remains mixed. The recent meta-analysis found increased blood NAD levels but did not find significant effects across most of the clinically relevant metabolic measures it examined.

The responsible expectation is therefore wellness-oriented rather than age-reversal-oriented.

Wear-Time And Product Format

Kind Patches currently describes each unit as a single-use patch designed for up to eight hours of wear. The manufacturer advises using only one at a time and rotating the skin location between uses.

Those are manufacturer directions rather than evidence that eight hours produces a particular blood concentration of the ingredients.

The company also advises against placing the patch on wounds, broken skin, or sensitive skin and recommends stopping if irritation or an allergic reaction occurs.

Because adhesive patches remain in prolonged contact with skin, local tolerance is an important part of product suitability regardless of whether systemic absorption occurs.

Age Restriction Is Important

Kind Patches specifically recommends its NAD+ Patches for people aged 18 and older.

The brand notes that children and teenagers can have different biological needs and does not include NAD+ Patches among its stated exceptions for younger users.

For an Erothots product page, that should be treated as an important product limitation rather than hidden in small-print precautions.

NAD+ Patches are an adult wellness product according to the manufacturer.

Medication, Pregnancy And Nursing Precautions

Kind Patches advises against use during pregnancy or breastfeeding.

It also says people taking medication should consult a healthcare professional before using the patches.

That warning makes sense given the multi-ingredient formula.

The patch contains NMN, resveratrol, NAC, and two mushroom extracts rather than a single cosmetic ingredient sitting only on the surface of the skin.

The manufacturer also states that the patch should not be combined with products placed directly over it such as heating pads.

The FDA Disclaimer Matters

Kind Patches includes an unusually important statement in its own caution section:

The product’s claims have not been evaluated by the U.S. Food and Drug Administration or equivalent local regulators, and the product is not intended to diagnose, treat, cure, or prevent disease.

That means an ecommerce description should not convert wellness marketing into medical language.

Erothots would avoid presenting the patches as:

a treatment for chronic fatigue,

a treatment for cognitive decline,

a DNA-repair therapy,

a treatment for metabolic disease,

or a clinically proven age-reversal intervention.

Those descriptions would go substantially beyond the verified product information.

Product-Specific Evidence Versus Ingredient Evidence

This distinction is probably the most important part of evaluating NAD+ Patches.

A finished five-ingredient patch is not automatically clinically validated because scientific papers exist about its individual ingredients.

The evidence hierarchy looks more like this:

Strongest product evidence: a controlled human study using the exact finished patch and measuring relevant outcomes.

Next: pharmacokinetic research demonstrating how much NMN and the other actives are actually delivered through the skin.

Less direct: human studies of the same ingredient taken orally.

Even less direct: laboratory, animal, or mechanistic studies.

Kind Patches currently references scientific literature around individual ingredients, but its public product information reviewed here does not provide a finished-product human pharmacokinetic trial showing the systemic delivery rate of all five ingredients.

That does not establish that the patch provides no absorption. It means the degree of absorption and resulting clinical effect should not be assumed without appropriate evidence.

Current Ingredient Profile

Each current Kind Patches NAD+ Patch contains:

Nicotinamide Mononucleotide (NMN) — 6 mg

Resveratrol — 6 mg

N-Acetylcysteine (NAC) — 6 mg

Lion’s Mane Mushroom Extract — 4 mg

Cordyceps Extract — 3 mg.

The current product page does not provide a similarly detailed public composition breakdown for the complete adhesive matrix, backing material, or every inactive component used to manufacture the physical patch.

Erothots therefore would not add unverified claims such as latex-free, hypoallergenic, medical-grade adhesive, or a particular adhesive chemistry without further manufacturer documentation.

Erothots Take On NAD+ Patches

Kind Patches NAD+ Patches are more accurately understood as NMN-containing adult wellness patches than as patches containing NAD+ itself.

Each patch combines 6 mg NMN, 6 mg resveratrol, 6 mg NAC, 4 mg lion’s mane extract, and 3 mg cordyceps extract, with 30 patches supplied in the current pack.

The NAD+ science behind the product category is interesting. Human oral studies show that NMN can raise blood NAD concentrations, and that gives the ingredient genuine research relevance. At the same time, a recent systematic review found that many broader clinical outcomes did not significantly improve compared with controls, which argues against turning NAD+ supplementation into sweeping anti-aging promises.

The bigger unanswered question for this particular product is transdermal delivery. Skin is a significant biological barrier, and FDA research on regulated transdermal systems shows that successful systemic delivery depends on much more than putting an ingredient into an adhesive patch.

Kind Patches promotes direct skin absorption and sustained wellness support, but its current product information does not provide product-specific human pharmacokinetic data demonstrating the amount of NMN or the other ingredients delivered into circulation.

That makes the most responsible product description straightforward: a 30-count adult wellness patch containing NMN and four supporting ingredients, marketed for vitality and healthy-aging routines, with interesting ingredient-level science but limited publicly presented clinical evidence for the finished transdermal product itself.

The manufacturer also explicitly recommends the patches for adults 18 and over, advises against use during pregnancy or nursing, includes medication precautions, and states that its claims have not been evaluated by the FDA.